The company took stock of the work in the first three quarters to encourage the completion of the annual target.
Release time:
2020-10-23
Company takes stock of the work in the first three quarters
to encourage
to achieve the annual target. News from our newspaper 10# August 19 and 20 , the company held a third quarter business work analysis meeting to comprehensively review, summarize and analyze the work of each business sector in the first three quarters of 2020 to find problems, to find a way to do a good job in the fourth quarter and fully complete the work objectives set at the beginning of the year. At the
analysis meeting, the heads of each subordinate business section reported on the work in the first three quarters, focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work, pointed out the highlights, and analyzed the problems and deficiencies in the light of the operating data of various enterprises. As the future API R & D and production base of Jianfeng Pharmaceutical, North Carolina received "special treatment" this quarter, and the company held a special meeting to "prescribe the pulse" for the company's future business development ".
International Trade Company: Strengthen the standard, reduce the operating cost and speed up the platform construction
Conference pointed out that in recent years, Jianfeng International Trade Company has accelerated the business transformation, market expansion and strengthened the management standardization construction, and made certain progress, but there is still a gap with the target requirements of the group company. With the change of the business model and enterprise scale, we should further achieve breakthroughs from the following aspects as soon as possible: further sort out and standardize the work process, reduce unnecessary management links, strengthen the sense of responsibility and cost control, and reduce the overall operating cost; From the image of the park, business process to internal assessment, we should do a good job in the standardization of park management in an all-round way, and set up systems and standards based on the existing business requirements to ensure that the standards are practical, the work process is efficient and the responsibilities are clear; strengthen the cultivation of new markets and new businesses, strengthen the introduction of futures delivery products, and improve profitability; accelerate the construction of third-party freight platforms to attract upstream and downstream customers and freight resources; strengthen the construction progress, cost, construction quality and safety management of new warehouses to ensure Early use; strengthen the maintenance of the original warehouse; pay attention to international and domestic economic trends and RMB exchange rates to avoid exchange risks; safety as the first premise to carry out the operation and management work.
Cable Company: Reduce costs, improve capabilities, seize opportunities
Cable Company has clear working ideas and bright spots in team building, which has been unanimously affirmed by the leaders of the Group Company. The meeting required Jianfeng Cable Company to further improve its production and quality management capabilities, improve production and quality control standards, strive to improve product qualification rates, reduce production costs, and enhance the company's response to market changes in response to the current multi-variety, multi-specification, and small-batch business model; further improve the market model, sales model, and business undertaking model to enhance profitability; strengthen the acquisition of access qualifications for various specialized industries, improve the ability to undertake business; seize the current opportunities to strengthen urban rail and subway transportation construction in various places, create the image of specialized cable manufacturers, and seek market breakthroughs.
Health Technology Company: Clarify the thinking, grasp the key points and improve the efficiency
Meeting requires the management team of Jianfeng Health Technology Company to carefully clarify the thinking and define the development direction; Carefully sort out and analyze the existing product lines, focus on key products with strong profitability, and do a good job in quality management and market development; Clear product development ideas and introduce competitive products for the future market; do a good job of inventory management and fund management, further optimize and refine management, improve the overall efficiency of the enterprise.
Cement Plate: Optimize Management, Improve Efficiency and Prevent Risks
In view of the common problems existing in the cement plate of the company, the meeting requires all cement enterprises to strengthen the application of informatization and intelligence, optimize and adjust the organizational structure, further improve the management efficiency and enterprise operation efficiency according to their own reality and the overall development of the cement industry. Further improve the internal responsibility assessment, to achieve clear and concise work process and post responsibilities; To set standards for advanced enterprises, strengthen technological transformation and innovation, and improve the reliability of equipment operation; Strengthen environmental protection management requirements and on-site renovation, and create civilized and sanitary factories; Around the annual target, force all work links to ensure that production management, quality management and cost control are in place; Improve sales capacity, grasp the core regional market and expand the key project market; strengthen learning through various forms and ways, learn from internal and external experiences and lessons, and improve the overall quality and skill level of the team; according to the current economic environment, there are many uncertain factors and the increasingly fierce competition in the cement industry, do a good job in preventing possible market risks and do a good job in the corresponding market convergence. The
meeting also required Daye Peak and Yunnan Peak to make preparations for the next technological transformation. Huang Ping Peak is required to strengthen on-site renovation, strengthen team building, and achieve production standards and production and sales balance as soon as possible.
Pharmaceutical Sector: Strengthen Responsibility, Improve Execution, Innovate Thinking, Improve Efficiency
Meeting Requires Managers at All Levels of Jianfeng Pharmaceutical Company to Strengthen Responsibility and Responsibility Awareness, Build Confidence, Effectively Improve Execution, Deal with Changes and Difficulties Brought by Various Uncertain Factors with Courage and Wisdom, and Fundamentally Solve the "Short Board" Problem in Enterprises; Deal with the Market with Innovative Thinking, improve the market response ability, market planning ability and market system control ability, straighten out the existing market order, clarify the market performance of each product, and plan and promote the listing of new products in more scientific and effective ways and methods; do a good job in improving work Efficiency is a big article, through informatization, intelligent construction and management system optimization, reasonable organization and arrangement of personnel to improve overall efficiency; strengthen the innovation of internal production management and process technology; speed up the progress of product research and development and launch, while strengthening the construction of its own R & D platform and R & D team, improve the control ability of cooperative development of products; strengthen cost control from all production links for the lowest cost of standard and quality products; strengthen the management of various technological transformation and speed up the construction of international projects; Pharmaceutical business should build confidence and strengthen the improvement of internal management, timely grasp and seize opportunities, control costs, play their own advantages.
In view of the current business situation of North Carolina, the meeting asked the management team of North Carolina to earnestly understand the current situation of the market and competitors, further clarify the positioning and development direction of the enterprise, establish confidence, and find and solve the current problems from the perspective of future development. Make careful calculations from each business link to establish comparative advantages in technology and technology; Fully introduce the cost-leading force mechanism, comprehensively improve the management level through intelligent and information construction, reduce various management and production costs; starting from the advantages of the company's technology, process, scale, and resource matching, scientifically select and develop products, and do a good job in innovative drugs and innovative products Research and development; do a good job in resource integration among subordinate enterprises to improve labor productivity. (this newspaper reporter)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31